Literature DB >> 4102207

Delayed hypersensitivity in mycoplasma pneumoniae infections.

H Mizutani, T Kitayama, A Hayakawa, E Nagayama.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 4102207     DOI: 10.1016/s0140-6736(71)91956-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Effect of Mycoplasma pheumoniae infection on cell-mediated immunity.

Authors:  G Biberfeld; G Sterner
Journal:  Infection       Date:  1976       Impact factor: 3.553

Review 2.  [Hepatitis-associated antigen: clinical and immunological significance].

Authors:  P A Berg
Journal:  Klin Wochenschr       Date:  1972-02-01

3.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1beta (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells.

Authors:  Xiangle Sun; Harlan P Jones; Lisa M Hodge; Jerry W Simecka
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model.

Authors:  Takeshi Saraya; Koh Nakata; Kazuhide Nakagaki; Natsuki Motoi; Kuniko Iihara; Yasunori Fujioka; Teruaki Oka; Daisuke Kurai; Hiroo Wada; Haruyuki Ishii; Haruhiko Taguchi; Shigeru Kamiya; Hajime Goto
Journal:  Results Immunol       Date:  2011-11-11

6.  Animal model of Mycoplasma pneumoniae infection using germfree mice.

Authors:  Masayuki Hayakawa; Haruhiko Taguchi; Shigeru Kamiya; Yasunori Fujioka; Hidehiro Watanabe; Shin Kawai; Hiroyuki Kobayashi
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 7.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 8.  Correlation between Radiological and Pathological Findings in Patients with Mycoplasma pneumoniae Pneumonia.

Authors:  Hiroshi Tanaka
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

Review 9.  Infection with and Carriage of Mycoplasma pneumoniae in Children.

Authors:  Patrick M Meyer Sauteur; Wendy W J Unger; David Nadal; Christoph Berger; Cornelis Vink; Annemarie M C van Rossum
Journal:  Front Microbiol       Date:  2016-03-23       Impact factor: 5.640

10.  Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.

Authors:  Akihiro Tamura; Kousaku Matsubara; Takayuki Tanaka; Hiroyuki Nigami; Kazuo Yura; Takashi Fukaya
Journal:  J Infect       Date:  2008-07-25       Impact factor: 6.072

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.